Advertisement

Reproducibility of the electronic chromoendoscopy PICaSSO score (Paddington International Virtual ChromoendoScopy ScOre) in ulcerative colitis using multiple endoscopic platforms: a prospective multicenter international study (with video)

Published:February 16, 2022DOI:https://doi.org/10.1016/j.gie.2022.02.012

      Background and Aims

      Endoscopic and histologic remission (HR) are key therapeutic targets in the management of ulcerative colitis (UC). The aim of this study was to evaluate the reproducibility of the Paddington International virtual ChromoendoScopy ScOre (PICaSSO), a virtual chromoendoscopy score originally validated by use of the iSCAN platform, with the narrow-band imaging (NBI), linked-color imaging (LCI), and blue-laser imaging (BLI) platforms.

      Methods

      We evaluated endoscopic activity using the Mayo Endoscopic Score (MES), the Ulcerative Colitis Endoscopic Index of Severity (UCEIS), and PICaSSO in 159 UC patients (78 NBI and 81 BLI/LCI) who underwent colonoscopy in 2 tertiary referral centers. HR was defined by the Robarts Histopathology Index (RHI) and the Nancy Histologic Index (NHI). Receiver operating characteristic curves were plotted to evaluate endoscopic scores for the prediction of HR. Intraclass correlation coefficients (ICC) between endoscopists were evaluated.

      Results

      PICaSSO had an ICC of 0.825 when the NBI and BLI/LCI cohorts were combined, higher than MES and UCEIS. The correlation between PICaSSO and RHI and NHI was 0.83 and 0.79 in the NBI cohort and between 0.63 and 0.65 in LCI/BLI. In the NBI cohort, the accuracy of MES, UCEIS, and PICaSSO was 0.936, 0.897, and 0.808 for HR measured by RHI and 0.897, 0.885, and 0.821 by NHI, respectively. In the BLI/LCI cohort, the accuracy of MES, UCEIS, LCI PICaSSO and BLI PICaSSO was 0.765, 0.778, 0.827, and 0.79 to predict HR with RHI and NHI, respectively.

      Conclusions

      The PICaSSO score can be consistently and accurately reproduced with NBI and LCI/BLI and therefore can be applied to all virtual electronic chromoendoscopy platforms.

      Graphical abstract

      Abbreviations:

      AUROC (area under receiver operating characteristic), BLI (blue-light imaging), HD (high definition), HR (histologic remission), ICC (intraclass correlation coefficient), LCI (linked-color imaging), MES (Mayo Endoscopic Score), MH (mucosal healing), NPV (negative predictive value), PPV (positive predictive value), NBI (narrow-band imaging), NHI (Nancy Histologic Index), PICaSSO (Paddington International Virtual ChromoendoScopy ScOre), RHI (Robarts Histopathology Index), ROC (receiver operating characteristic), UC (ulcerative colitis), UCEIS (ulcerative colitis endoscopic index score), VCE (virtual electronic chromoendoscopy), WLE (white-light endoscopy)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Gastrointestinal Endoscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Peyrin-Biroulet L.
        • Sandborn W.
        • Sands B.E.
        • et al.
        Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target.
        Am J Gastroenterol. 2015; 110: 1324-1338
        • Turner D.
        • Ricciuto A.
        • Lewis A.
        • et al.
        STRIDE-II: an update the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD.
        Gastroenterology. 2021; 160: 1570-1583
        • Sands B.E.
        • Sandborn W.J.
        • Panaccione R.
        • et al.
        Ustekinumab as induction and maintenance therapy for ulcerative colitis.
        N Engl J Med. 2019; 381: 1201-1214
        • Li K.
        • Marano C.
        • Zhang H.
        • et al.
        Relationship between combined histologic and endoscopic endpoints and efficacy of ustekinumab treatment in patients with ulcerative colitis.
        Gastroenterology. 2020; 159: 2052-2064
        • Gupta A.
        • Yu A.
        • Peyrin-Biroulet L.
        • et al.
        Treat to target: the role of histologic healing in inflammatory bowel diseases: a systematic review and meta-analysis.
        Clin Gastroenterol Hepatol. 2021; 19: 1800-1813
        • Yoon H.
        • Jangi S.
        • Dulai P.S.
        • et al.
        Incremental benefit of achieving endoscopic and histologic remission in patients with ulcerative colitis: a systematic review and meta-analysis.
        Gastroenterology. 2020; 159: 1262-1275 e7
        • Bessissow T.
        • Lemmens B.
        • Ferrante M.
        • et al.
        Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing.
        Am J Gastroenterol. 2012; 107: 1684-1692
        • Bryant R.V.
        • Winer S.
        • Travis S.P.
        • et al.
        Systematic review: histological remission in inflammatory bowel disease: is ‘complete’ remission the new treatment paradigm? An IOIBD initiative.
        J Crohns Colitis. 2014; 8: 1582-1597
        • Park S.
        • Abdi T.
        • Gentry M.
        • et al.
        Histological disease activity as a predictor of clinical relapse among patients with ulcerative colitis: systematic review and meta-analysis.
        Am J Gastroenterol. 2016; 111: 1692-1701
        • Iacucci M.
        • Furfaro F.
        • Matsumoto T.
        • et al.
        Advanced endoscopic techniques in the assessment of inflammatory bowel disease: new technology, new era.
        Gut. 2019; 68: 562-572
        • Iacucci M.
        • Daperno M.
        • Lazarev M.
        • et al.
        Development and reliability of the new endoscopic virtual chromoendoscopy score: the PICaSSO (Paddington International Virtual ChromoendoScopy ScOre) in ulcerative colitis.
        Gastrointest Endosc. 2017; 86: 1118-1127.e5
        • Trivedi P.J.
        • Kiesslich R.
        • Hodson J.
        • et al.
        The Paddington International Virtual Chromoendoscopy Score in ulcerative colitis exhibits very good inter-rater agreement after computerized module training: a multicenter study across academic and community practice (with video).
        Gastrointest Endosc. 2018; 88: 95-106.e2
        • Iacucci M.
        • Smith S.C.L.
        • Bazarova A.
        • et al.
        An international multicenter real-life prospective study of electronic chromoendoscopy score PICaSSO in ulcerative colitis.
        Gastroenterology. 2021; 160: 1558-1569.e8
        • Togashi K.
        • Nemoto D.
        • Utano K.
        • et al.
        Blue laser imaging endoscopy system for the early detection and characterization of colorectal lesions: a guide for the endoscopist.
        Ther Adv Gastroenterol. 2016; 9: 50-56
        • Schroeder K.W.
        • Tremaine W.J.
        • Ilstrup D.M.
        Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study.
        N Engl J Med. 1987; 317: 1625-1629
        • Travis S.P.
        • Schnell D.
        • Krzeski P.
        • et al.
        Reliability and initial validation of the ulcerative colitis endoscopic index of severity.
        Gastroenterology. 2013; 145: 987-995
        • Mosli M.H.
        • Feagan B.G.
        • Zou G.
        • et al.
        Development and validation of a histological index for UC.
        Gut. 2017; 66: 50-58
        • Marchal-Bressenot A.
        • Salleron J.
        • Boulagnon-Rombi C.
        • et al.
        Development and validation of the Nancy histological index for UC.
        Gut. 2017; 66: 43-49
        • Pai R.K.
        • Khanna R.
        • D'Haens G.R.
        • et al.
        Definitions of response and remission for the Robarts histopathology index.
        Gut. 2019; 68: 2101-2102
        • Robin X.
        • Turck N.
        • Hainard A.
        • et al.
        pROC: an open-source package for R and S+ to analyze and compare ROC curves.
        BMC Bioinformatics. 2011; 12: 77
      1. Gamer M, Lemon J, Singh IFP. Various coefficients of interrater reliability and agreement. Availalbe at: https://cran.r-project.org/web/packages/irr/. Accessed March 10, 2022.

        • Oremus M.
        • Oremus C.
        • Hall G.B.
        • et al.
        Cognition Systematic Review T. Inter-rater and test-retest reliability of quality assessments by novice student raters using the Jadad and Newcastle-Ottawa scales.
        BMJ Open. 2012; 2e001368
        • May J.O.
        • Looney S.W.
        Sample size charts for Spearman and Kendall coefficients.
        J Biometrics Biostatistics. 2020; 11: 1-7
        • Matsumoto K.
        • Oka S.
        • Tanaka S.
        • et al.
        Clinical usefulness of linked color imaging for evaluation of endoscopic activity and prediction of relapse in ulcerative colitis.
        Int J Colorectal Dis. 2021; 36: 1053-1061
        • Uchiyama K.
        • Takagi T.
        • Kashiwagi S.
        • et al.
        Assessment of endoscopic mucosal healing of ulcerative colitis using linked colour imaging, a novel endoscopic enhancement system.
        J Crohns Colitis. 2017; 11: 963-969
        • Iacucci M.
        • Cannatelli R.
        • Gui X.
        • et al.
        Assessment of endoscopic healing by using advanced technologies reflects histological healing in ulcerative colitis.
        J Crohns Colitis. 2020; 14: 1282-1289
        • Cannatelli R.
        • Bazarova A.
        • Zardo D.
        • et al.
        Fecal calprotectin thresholds to predict endoscopic remission using advanced optical enhancement techniques and histological remission in IBD patients.
        Inflamm Bowel Dis. 2021; 27: 647-654